A Study of LNP3794 in Subjects With NRAS/KRAS Mutated Advanced or Metastatic Refractory Solid Tumors
Clinical trial NCT05187858 · COMPLETED
Trial details
- NCT number
- NCT05187858
- Sponsor
- Lupin Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-22
- Primary completion
- 2022-02-23
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.